The company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes. All of the shares of common stock and associated warrants are being offered by the company. ThinkEquity acted as sole book running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIVI:
- BioVie receives notice of allowance for Japan patent application
- BioVie receives notice of allowance for U.S. patent covering liquid terlipressin
- BioVie Bolsters Capital with Public Offering and Warrant Adjustment
- BioVie Launches Public Offering for Corporate Growth
- Morning Movers: Light & Wonder sinks following injunction for Aristocrat